Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU Funding Helps Fight Liver Cancer

22.02.2005


The fight against liver cancer, one of the leading causes of cancer death worldwide, is being helped by 2.5 million euros from the EU’s Framework Programme.



PONT (Parallel Optimisation of New Technologies for Post-Genomics Drug Discovery) is a three-year specific targeted research project involving four biotechnology companies and two academic partners from the UK, Austria and Germany. It aims to bridge the gap in the drug development pipeline using a new approach in post-genomics drug discovery. The project combines optimal technologies with the best scientific expertise to develop new medical therapies.

The overall project will concentrate on three areas where Europe is in a relatively favourable position compared with the US - human tissue resources, ribonucleic acid (RNA) technology, and structural proteomics. However, the initial focus will be on the development of genomics targets in hepatocellular carcinoma (HCC) or liver cancer as it is one of the leading causes of cancer death worldwide and has a very poor prognosis.


“PONT combines cutting-edge technologies and associated know-how developed specifically by the project partners in a collaborative multinational effort to establish a unique metaplatform for post-genomics drug development” says Peter Kane, Senior Director of Research Operations at Tripos Discovery Research - one of the UK project partners. “The project will provide a new paradigm for drug development, resulting in a dramatic reduction in late-stage drug target attrition for preclinical development activities and therefore shortening the time to develop new drugs by two years or more. The programme addresses the general lack of efficiency in converting promising targets from genomics research into effective new drugs, potentially achieving significant time and cost savings that will increase European competitiveness in the biotechnology Industry at many levels.”

“Pont will not only bridge the gap between the wealth of genomics targets and shortcomings in development of these targets, but also the gap between a fragmented biotech industry and the few very big pharma companies. The project integrates four companies in a highly interactive workflow that will provide a model establishing a strong position for biotech precision technology platforms.”

As well as increasing the overall competitiveness of the European biotechnology industry, the successful implementation of the PONT strategy will also provide important and valuable new therapeutic prospects. In contrast to the traditional approach, PONT will undertake pre-clinical drug development with a parallel instead of a sequential approach. This will save years when it comes to the trials.

“The PONT project shows the value of investing EU funding in effective research and development that will bring benefits to us all”, says Claire Horton, FP6UKs National Contact Point for the Life Sciences, Genomics and Biotechnology for Health programme. “It provides the opportunity to bring together the expertise of scientists from throughout Europe, enabling them to work together in finding solutions to many of today’s problems.

“The current Framework Programme (FP6) runs until 2006 and organisations wanting free, easy to access, information on the €19bn (euros) of funding available to support internationally collaborative R&D should log on to http://fp6uk.ost.gov.uk or call central telephone support on 0870 600 6080.”

Dave Sanders | alfa
Further information:
http://fp6uk.ost.gov.uk

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Molecular switch will facilitate the development of pioneering electro-optical devices

24.05.2018 | Power and Electrical Engineering

Research reveals how order first appears in liquid crystals

23.05.2018 | Life Sciences

Space-like gravity weakens biochemical signals in muscle formation

23.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>